Major risk factors for cardiovascular disease - Debunking the "only 50%" myth

[21] National Cholesterol Education Program, 1994, Circulation, V89, P1333, DOI 10.1161/01.CIR.89.3.1333

[22] Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile - A randomized controlled trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (17): : 2215 - 2223

[23] Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (26) : 1959 - 1965

[24] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) : 973 - 979

[25] Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) : 1557 - 1565

[26] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial [J]. LANCET, 2003, 361 (9364) : 1149 - 1158

[27] Primordial prevention of cardiovascular disease risk factors: Panel summary [J]. PREVENTIVE MEDICINE, 1999, 29 (06) : S130 - S135

[28] Prediction of coronary heart disease using risk factor categories [J]. CIRCULATION, 1998, 97 (18) : 1837 - 1847

[29] Yusuf S, 2000, NEW ENGL J MED, V342, P145

[21] National Cholesterol Education Program, 1994, Circulation, V89, P1333, DOI 10.1161/01.CIR.89.3.1333

[22] Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile - A randomized controlled trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (17): : 2215 - 2223

[23] Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (26) : 1959 - 1965

[24] Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (14) : 973 - 979

[25] Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) : 1557 - 1565

[26] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial [J]. LANCET, 2003, 361 (9364) : 1149 - 1158

[27] Primordial prevention of cardiovascular disease risk factors: Panel summary [J]. PREVENTIVE MEDICINE, 1999, 29 (06) : S130 - S135

[28] Prediction of coronary heart disease using risk factor categories [J]. CIRCULATION, 1998, 97 (18) : 1837 - 1847

[29] Yusuf S, 2000, NEW ENGL J MED, V342, P145